Startups

Director, Protein Science

Alloy Therapeutics · Remote (US) · Remote

← All jobs
About Alloy Therapeutics

Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in antibodies and TCRs.

About the role

We are Alloy Therapeutics — a biotechnology ecosystem and Product Development Organization (PDO) empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics.

What they're looking for

  • Drive : Scientific direction and execution of monoclonal discovery and multispecific engineering campaigns
  • Innovate : Ensure the application of cutting-edge technologies and methodologies in protein expression
  • Collaborate : Integrate protein engineering and cutting-edge efforts efficiently into product offerings and engage with external collaborators in discovery of biologics
  • Deliver : Efficient execution of partner projects balancing quality, timelines, and costs, while ensuring successful completion of therapeutic discovery that meet our partners’ objectives
  • Lead : Marshal, inspire, and mentor a cross-functional team of scientists. Lead by example by going the extra mile to ensure we are successful delivering on projects
  • Communicate : Communicate effectively with key stakeholders externally and internally, fostering productive interactions both upward and downward, and across teams at different sites
More about this role

Role Location: Waltham, MA

The Company

We are Alloy Therapeutics — a biotechnology ecosystem and Product Development Organization (PDO) empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. The company facilitates affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. At Alloy, we believe our industry should compete on getting the best drugs to patients as quickly as possible, not exclusive access to the best platforms. As a reflection of our relentless commitment to the scientific community, we reinvest 100% of our revenue in innovation and access to innovation. May the Best Drug Win.

Alloy has evolved from a startup into a global product development organization operating 11 divisions across 5 research sites in 4 countries on 3 continents. Our model - Integrated Independence - combines centralized capabilities with entrepreneurial operating divisions....

Read the full posting on Alloy Therapeutics's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.